RetiSpec is a medical imaging company developing a tool for the early detection of Alzheimer’s disease biomarkers in the eye.

Our goal is to enable widespread early detection of Alzheimer’s disease with accessible and scalable screening.

Thanks & credit to Lyon Road Art

In a quick eye exam, RetiSpec  opens a window of opportunity for timely and specific therapeutic interventions, so the progression of the disease may be slowed or even prevented. 

Simple Eye Exam

Adam Gribble, PhD

Lead Scientist

Adam has 7 years of hands-on experience in both fundamental and applied optics research, including bio-imaging, spectral analysis, and development of optical instrumentation

Catherine Bornbaum, PhD, MBA

Head of Clinical Operations & Partnerships

Catherine is a health scientist and MBA with 10+ years of experience leading large scale health research operations. In 2019, she was named one of the 100 Best & Brightest Executive MBAs globally by Poets & Quants.

Eliav Shaked, M.Sc


Eliav is an experienced biomedical engineer having led several medical products from ideation to launch, and a recent graduate of Singularity University’s flagship GSP program (NASA/Google)

Jared Westreich, M.Sc

Data Scientist

Jared is an experienced data scientist with a background in medical biophysics and expertise in machine learning techniques

Roy Kirshon, MBA

Business Operations

Roy is a biomedical engineer, and an MBA. With 10 years of experience building new initiatives and working with ventures, Roy has lead new technologies and early stage startups to market

Michael Wood, PhD


Michael is an experienced R&D director with expertise in medical biophysics. He has managed large scale programs as well as commercialization over the past 8 years

Maïlis Bietenhader, PhD

Ocular Imaging Specialist

Mailis is an expert in ophthalmic imaging. After a PhD in Molecular Biology and a successful post-doctoral fellowship at the University of Toronto, she combines her background in research with 6 years of clinical experience


RetiSpec Receives Award from Alzheimer's Drug Discovery Foundation (ADDF)

Oct 08, 2019

Howard Fillit, M.D., Founding Executive Director and Chief Science Officer of ADDF, said, "We believe that RetiSpec's retinal scanner stands out and shows promise as a unique diagnostic tool among a range of technologies in development. The technology has the potential to facilitate early diagnosis, improve the lives of patients and their loved ones and save the healthcare system money and resources. The technology will also be useful in making clinical trials for Alzheimer's disease more efficient."

Screen Shot 2019-07-28 at 9.38.34 PM.png

Announcement of RetiSpec's Clinical Study in Israel

April 3, 2018

The clinical study at Sheba Medical Centre will begin in January 2019 and will investigate the RetiSpec technology to detect individuals with early signs of Alzheimer's Disease compared to current modalities.


Could an eye scan be used to diagnose Alzheimer's disease?

August 6, 2019

A Toronto clinic is first in the world to test retina scans that may be able to diagnose Alzheimer's disease using a hypersensitive device developed in Canada.


CABHI is working with RetiSpec to accelerate its technology in Ontario and Canada 

March 04, 2019

The CABHI-funded RetiSpec trial will determine the safety and effectiveness of the technology through human clinical testing, and help spur commercialization of the technology in Ontario and Canada – to get it into the hands of those who need it most.


University of Minnesota collaborates with medical imaging startup RetiSpec 

October 17, 2018

The University’s collaboration with RetiSpec comes following a successful pilot clinical study demonstrating the capabilities of the technology, involving 31 participants both with and without Alzheimer’s. 

From the Lab to Life: A Retinal Scanner for Early Detection of Alzheimer’s Disease

July 17, 2018

Ontario Brain Institute backed RetiSpec to accelerate growth in Ontario, Canada. RetiSpec has developed software and “plug and play” hardware components that can be applied directly to existing retinal cameras readily found in optometrists’ offices.


If you are interested in partnering with RetiSpec,

please contact us at hello@retispec.com

Contact Us

  • Grey LinkedIn Icon
  • Grey Twitter Icon

Toronto, ON, Canada

© 2019 RetiSpec Inc. All rights reserved.